What’s Going On With AstraZeneca Stock Today?

Shares in European pharmaceutical giant AstraZeneca Plc (NASDAQ: AZN) are down amid speculations swirling around the potential departure of AstraZeneca’s Chief Executive, Pascal Soriot. The trigger for this sudden decline can be traced to a report published in the Mail on Sunday newspaper that writes that Soriot privately told friends and trusted advisers that he wanted to leave […]

‘Wolf Of Wall Street’ Embraces Ibogaine For Addiction Recovery With Help Of ‘Psychedelic Concierge’

Jordan Belfort, the real-life persona behind Leo Di Caprio’s “Wolf of Wall Street,” recently talked about finding a cure for his cocaine addiction and opiate urges: ibogaine, which comes from a West African shrub now being studied to treat conditions like TBI, PTSD, depression and addiction. Belfort said he sees the natural psychedelic as a “magic bullet” for the opioid crisis. He told […]

What Retail Traders Really Think About Hawaiian Electric

Hawaiian Electric Industries, Inc. (NYSE:HE) recently became the focal point of a gripping narrative, captivating the attention of retail traders. Over the past month, this utility company has found itself navigating a tumultuous sea of controversy, legal battles and extreme market turbulence. In the Russell 1000 Index, Hawaiian Electric has stood out as one of […]

Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression

COMPASS Pathways plc (NASDAQ: CMPS) shared the results from research on the potential of its novel AI technologies to support its proprietary COMP360 psilocybin treatment for Treatment-Resistant Depression (TRD.) COMPASS is oner of the biggest players in the psychedelics biotech space today. CEO Kabir Nath said the results are “exciting” because they signal a potential prediction of long-term patient […]

UK Psychedelics Update: MPs Seek Rescheduling, Safe Consumption Sites, OD Prevention Fund

The U.K.’s drug policy and reform is underway through several paths. On August 30, Parliament’s Home Affairs committee presented a report urging the reclassification of psilocybin mushrooms and other psychedelics to Schedule 2 to support the “growing body of evidence” with further clinical research on the substances’ potential medical and therapeutic benefits. The report holds […]

US Steel’s Bid Review Buzz: Evaluates Confidential Buyout Offers

United States Steel Corp (NYSE: X) has reportedly engaged in confidentiality agreements with several interested parties and has begun sharing due diligence information.  This strategic move comes as U.S. Steel evaluates bids for the entire company or specific parts of its operations. In a letter addressed to shareholders, Chief Executive David Burritt and Chairman David Sutherland […]

Did Google Just Accidentally Leak Official Images Of Pixel 8 Pro?

Alphabet Inc.’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google has inadvertently leaked its upcoming Pixel 8 Pro smartphone, giving us the first official glimpse at the phone’s camera design. What Happened: Google seems to be having a hard time keeping a lid on Pixel 8 Pro leaks, and this time, it has no one but itself to blame. The […]

Second Psychedelics Merger Of The Week? Silo Wellness To Buy Jamaica-Based Business For $31.9M

Silo Wellness (OTCQB: SILFF) has confirmed its intention to acquire all issued and outstanding securities of NUGL Inc./Kaya Group (OTC Pink: NUGL) in an arms-length transaction valued at $31.9 (CA$43.3) million. The news comes shortly after Cybin’s (NYSE: CYBN) proposed acquisition of Small Pharma (OTCMKTS: DMTTF), and was somewhat anticipated by Silo NUGL’s recent business partnership. The number reflects the […]